Recent genome-wide sequencing studies revealed that ~10–15% of small cell lung cancers, another subset of lung cancer, harbor a gene truncation in the p300 or CBP, as well as loss-of-function mutations clustered in the HAT domain [16]. This evidence concerns the gene CREBBP and lung carcinoma.